Search

Your search keyword '"Matzdorff, Axel"' showing total 828 results

Search Constraints

Start Over You searched for: Author "Matzdorff, Axel" Remove constraint Author: "Matzdorff, Axel"
828 results on '"Matzdorff, Axel"'

Search Results

4. Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX

5. Expert Report on Immune Thrombocytopenia - Current Diagnostics and Treatment Recommendations from an Expert Group from Austria, Germany, and Switzerland

7. Expertenreport Immunthrombozytopenie - Aktuelle Diagnostik und Therapie

11. Funktionsprüfungen und Diagnostik als Grundlagen der Begutachtung

12. Krebskrankheiten

15. Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis and Hemostasis Research (GTH)

18. Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial

19. Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncology (ÖGHO) and Society of Thrombosis and Haemostasis Research (GTH e.V.)

22. DPYD Genotyping to Predict Adverse Events Following Treatment With Fluorouracil-Based Adjuvant Chemotherapy in Patients With Stage III Colon Cancer: A Secondary Analysis of the PETACC-8 Randomized Clinical Trial

24. The EHA Research Roadmap: Platelet Disorders

25. Primary Thromboprophylaxis in Patients with Malignancies: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO), the Society of Thrombosis and Hemostasis Research (GTH), and the Austrian Society of Hematology and Oncology (ÖGHO)

26. Leitlinie : Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie h��matologischer und onkologischer Erkrankungen : ICD10: D69.3

31. Stellungnahme zur Nutzenbewertung des G-BA von Arzneimitteln gemäß § 35a SGB V, veröffentlicht am 1. Oktober 2020, Vorgangsnummer 2020-07-01-D-556, IQWiG Bericht Nr. 975

32. Leitlinie : Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen : ICD10: D69.3

33. 4.12 Angiodysplasien des (Dünn-)Darms

34. 4.23 Staphylococcus-aureus-Infektion

35. 4.11 (Dünndarm-)Karzinoid

36. 1.2 Blutstillung (primäre Hämostase)

37. 1.2 Physiologie

38. 2.3 Diagnostik

39. 4.2 ANCA-assoziierte Vaskulitiden der kleinen Gefäße

40. 6.1 Allgemeines

41. 2.5 Hiatushernie

42. 2.9 Der transplantierte Patient

43. 2.9 Invasive Methoden

44. 5.6 Prognose

45. 3.4 Bildgebende Verfahren

46. 2.3 Beinödem

47. 10.5 Kyphoskoliose

48. 2.2 Einschätzung der Nierenfunktion

49. 1.5 Bewertungen der Befundkonstellationen

50. 7.1 Grundlagen

Catalog

Books, media, physical & digital resources